Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach

By Bäumler Michael   Stargardt Tom   Schreyögg Jonas   Busse Reinhard  

Applied Health Economics and Health Policy, Vol. 10, Iss. 4, 2012-07 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of drug-eluting stents: real-world scrutiny of the BASKET trial of real-world usage

By Cooper Liesl M   Linde-Zwirble Walter  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 3, 2006-05 ,pp. : 305-309

Informa Healthcare

Access to resources Recommend Favorite

Cost of Acute Myocardial Infarction in Hong Kong

By Lee Vivian W.Y.  

Disease Management & Health Outcomes, Vol. 13, Iss. 4, 2005-01 ,pp. : 281-285

Adis International

Access to resources Recommend Favorite

Current application and bioavailability of drug-eluting stents

By Escárcega Ricardo O   Baker Nevin C   Lipinski Michael J   Magalhaes Marco A   Minha Sa'ar   Omar Al-Fazir   Torguson Rebecca   Waksman Ron  

Expert Opinion on Drug Delivery, Vol. 11, Iss. 5, 2014-05 ,pp. : 689-709

Informa Healthcare

Access to resources Recommend Favorite

Drug-Eluting Stents in the Management of Coronary Artery Disease: Implications for Payors and Hospitals

By James B. Hermiller  

Disease Management & Health Outcomes, Vol. 13, Iss. 1, 2005-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite